Lfjimack

[Experimental Medicine & Rheumatology @EMR_QMUL]

Passionate about driving clinical research forward? Join us as a Clinical Trial Manager! @QMULWHRI
👩‍💻Apply here: https://t.co/urkEGLmfWG
⌛️Closing Date: 6 April
#ResearchOpportunity #ClinicalTrials #ResearcherJobs

[Experimental Medicine & Rheumatology @EMR_QMUL]

We're hiring! 🗣️
We are seeking an experienced Postdoctoral Research Assistant in histological, cellular, and molecular biology to contribute to the delivery of high-quality research at EMR @QMULWHRI
👩‍💻Apply here: https://t.co/FnOgL9jp5Y
⌛️Closing date: 11 March 2024

[3TR-IMI @3TR_IMI]

Hear more about the study and advances in RA treatment from Prof. Costantino Pitzalis @QMUL in an online talk next Monday, 20 Mar 2023, from 2 to 3.30 PM (UK time). The talk is aimed at people living with RA and their friends and family. Register here: https://t.co/0nqi9vofg3

[3TR-IMI @3TR_IMI]

We’re excited to share that our new #3TR Clinical Study “3TR-Precis-The-RA” investigating precision therapy in patients with #RheumatoidArthritis has just started! 🙌Find out more:
https://t.co/mTE6Z2weV7

[Experimental Medicine & Rheumatology @EMR_QMUL]

Only 6 days away!!!
@NRAS_UK @VersusArthritis #PrecisionMedicine

[FLAMIN-GO Project @FlaminGoH2020]

The new 3TR Trials- the promise of Personalised Medicine for RA Tickets, Mon 20 Mar 2023 at 14:00 | Eventbrite https://t.co/YUWXejDkUQ

[Experimental Medicine & Rheumatology @EMR_QMUL]

Applications are invited for a Teaching/Research Post: EMR CLINICAL SENIOR LECTURER post, at our Centre!

https://t.co/FvMl22LVVq

@EMR_QMUL
@QMULWHRI
@NHSBartsHealth
at the Department of #Rheumatology

[Experimental Medicine & Rheumatology @EMR_QMUL]

Interested in working in the vibrant EMR Centre?
An excellent Research Technician opportunity, calling for applicants. Apply via, https://t.co/KXrFNxpeCB

#biomedicine #research #rheumatology
Closing date is 27th July

@FlaminGoH2020
@EMR_QMUL
@QMULWHRI

[Stick to Science @Stick2Science]

The co-initiators of the #StickToScience initiative have sent an open letter to the EC President Ursula @vonderleyen asking her to intervene urgently in the critical issue for science created by the delay of the association of 🇬🇧 and 🇨🇭to #HorizonEurope.
https://t.co/KHUzAxWYgG

[EMEUNET @EMEUNET]

Chair elect of @EMEUNET @FeliceRivellese has the honour of the last talk of #ACR19 #ACR2019 presenting surprising results of a biopsy driven trial.

[Annals of the Rheumatic Diseases @eular_ARD]

Data from the R4-RA trial, exploring treatment response based on synovial tissue biopsies, shows that in B-cell poor synovitis #Tocilizumab is superior compared to #Rituximab. @FeliceRivellese #ACR19

[Healio Rheumatology @HealioRheum]

Dr. Constantino Pitzalis @QMUL @BartsHospital discusses his research into tocilizumab in RA in those w low b cell levels in synovial tissue, the world's first biopsy driven clinical trial https://t.co/I1C6niCpNN